Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)

PHASE2CompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

December 10, 2018

Primary Completion Date

December 14, 2021

Study Completion Date

December 14, 2021

Conditions
ConstipationParkinson Disease
Interventions
DRUG

Active Investigational Treatment ENT-01

ENT-01 will be administered in tablet form, once daily.

DRUG

Placebo Treatment

Placebo will be administered in tablet form, once daily.

Trial Locations (51)

10029

Icahn School of Medicine at Mount Sinai, New York

12208

Albany Medical College, Albany

13756

Dartmouth Hitchcock Medical Center, Lebanon

17033

Penn State University, Hershey

20007

Georgetown University Hospital, Washington D.C.

21075

Parkinson's and Movement Disorders Center of Maryland, Elkridge

23456

Sentara Neuroscience Institute, Norfolk

25701

University Physicians & Surgeons, Inc. dba Marshall Health, Huntington

27157

Wake Forest Baptist Medical Center, Wake Forest

27607

Raleigh Neurology Associates, Raleigh

29650

Interspond - Premier Neurology, Greer

29707

Interspond - Metrolina Neurological Associates, Old Point Station

30331

Atlanta Center for Medical Research, Atlanta

33145

Elias Research - Floridian Research Institute, Miami

33155

Elias Research - Allied Biomedical Research Institute, Miami

33175

Pharmax Research of South Florida, Miami

33407

Palm Beach Neurology and Premier Research Institute, West Palm Beach

33462

JEM Research Institute, Atlantis

33486

Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton

33603

University of South Florida, Tampa

33952

MEDSOL Clinical Research, Port Charlotte

33980

Parkinson's Disease Treatment Center of SWFL, Port Charlotte

34239

Intercoastal Medical Group, Sarasota

43614

University of Toledo Medical Center, Toledo

44095

Cleveland Clinic, Cleveland

45219

University of Cincinnati, Cincinnati

45459

Dayton Center for Neurological Disorders, Centerville

Elias Research - Neurology Diagnostics Research, Dayton

46011

BTC Network - Community Clinical Research Center, Anderson

48322

Henry Ford West Bloomfield Hospital, West Bloomfield

68506

Neurology Associates Clinical Research, Lincoln

70810

The NeuroMedical Center, P.C., Baton Rouge

71301

Interspond - The Neuromedical Clinic of Central Louisiana, Alexandria

72205

Clinical Trials, Inc., Little Rock

74136

The Movement Disorder Clinic of Oklahoma, Tulsa

75218

BTC Network - Neurological Associates of North Texas, Dallas

76021

North Texas Movement Disorders Institute, Bedford

77074

Clinical Trial Network, Houston

80113

Rocky Mountain Movement Disorders Center, Englewood

85351

Banner Sun Health Research Institute, Sun City

89128

Interspond - Neurology Center of Las Vegas, Las Vegas

91105

SC3 Research - Pasadena, Pasadena

91321

Trial Connections - Care Access Research, Santa Clarita, Santa Clarita

92708

The Parkinson's and Movement Disorder Institute, Fountain Valley

93030

Pacific Neuroscience Medical Group, Oxnard

93710

Neuro Pain Medical Center, Fresno

98034

Evergreen Health - Booth Gardner Parkinson's Care Center, Kirkland

06824

Associated Neurologist of Southern CT, Fairfield

06360

Care Access Research, Norwich, Norwich

08755

Evolution Research Group - Neuroscience Research Institution, Toms River

Neuroscience Researc Institute of NJ, Toms River

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Enterin Inc.

INDUSTRY